Published in Hum Psychopharmacol on December 01, 2009
Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev (2012) 1.67
Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors. PLoS One (2012) 0.87
Impact of ADHD and cannabis use on executive functioning in young adults. Drug Alcohol Depend (2013) 0.86
Comorbid trajectories of tobacco and marijuana use as related to psychological outcomes. Subst Abus (2012) 0.82
The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics. Int J Methods Psychiatr Res (2011) 0.81
Effects of marijuana use on prefrontal and parietal volumes and cognition in emerging adults. Psychopharmacology (Berl) (2015) 0.80
ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task. Brain Imaging Behav (2016) 0.77
The psychosocial determinants of the intention to avoid sexual engagement when intoxicated among young men in KwaZulu-Natal, South Africa. BMC Public Health (2016) 0.76
Understanding the Psychosocial Correlates of the Intention to Use Condoms among Young Men in KwaZulu-Natal, South Africa. Int J Environ Res Public Health (2017) 0.75
Neuropsychological Assessment Battery-Screening Module (S-NAB): performance in treatment-seeking cocaine users. Am J Drug Alcohol Abuse (2014) 0.75
Cost of disorders of the brain in Europe. Eur J Neurol (2005) 6.41
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet (2004) 3.91
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ (2011) 3.84
The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res (2003) 3.36
The prevalence of treated and untreated mental disorders in five countries. Health Aff (Millwood) (2003) 3.17
The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab (2010) 3.12
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation (2007) 3.01
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ (2004) 2.93
The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int (2013) 2.73
The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction (2008) 2.43
Parental major depression and the risk of depression and other mental disorders in offspring: a prospective-longitudinal community study. Arch Gen Psychiatry (2002) 2.41
Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Arch Gen Psychiatry (2007) 2.19
Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology. Drug Alcohol Depend (2002) 2.16
Total somatic symptom score as a predictor of health outcome in somatic symptom disorders. Br J Psychiatry (2013) 2.16
Common and distinct amygdala-function perturbations in depressed vs anxious adolescents. Arch Gen Psychiatry (2009) 2.12
Early expression of negative/disorganized symptoms predicting psychotic experiences and subsequent clinical psychosis: a 10-year study. Am J Psychiatry (2010) 2.10
Using screening tools to identify neuropathic pain. Pain (2006) 2.09
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology (2012) 1.94
Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull (2009) 1.93
Human and economic burden of generalized anxiety disorder. Depress Anxiety (2008) 1.92
Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry (2009) 1.88
Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab (2006) 1.87
Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism (2010) 1.81
Prediction of transition from common adolescent bipolar experiences to bipolar disorder: 10-year study. Br J Psychiatry (2010) 1.75
Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol (2005) 1.73
Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend (2007) 1.71
Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. Am J Psychiatry (2013) 1.71
Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biol Psychiatry (2012) 1.70
ROAMER: roadmap for mental health research in Europe. Int J Methods Psychiatr Res (2014) 1.67
What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug Alcohol Depend (2002) 1.67
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol (2008) 1.62
Longitudinal course of posttraumatic stress disorder and posttraumatic stress disorder symptoms in a community sample of adolescents and young adults. Am J Psychiatry (2005) 1.61
Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication. Psychol Med (2005) 1.59
Anxiety disorders in mothers and their children: prospective longitudinal community study. Br J Psychiatry (2008) 1.55
Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research. Schizophr Bull (2012) 1.50
Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease. Gastroenterology (2010) 1.50
Prevalence of mental health problems among children and adolescents in Germany: results of the BELLA study within the National Health Interview and Examination Survey. Eur Child Adolesc Psychiatry (2008) 1.49
Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry (2010) 1.49
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens (2004) 1.48
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project. J Psychiatr Res (2008) 1.45
What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry (2004) 1.45
Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol (2002) 1.45
Smoking increases the risk of panic: findings from a prospective community study. Arch Gen Psychiatry (2003) 1.43
High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens (2004) 1.43
P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet (2006) 1.42
Patterns and correlates of generalized anxiety disorder in community samples. J Clin Psychiatry (2002) 1.41
Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. Psychol Med (2005) 1.41
Impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness. Br J Psychiatry (2006) 1.40
Computerized ambulatory monitoring in psychiatry: a multi-site collaborative study of acceptability, compliance, and reactivity. Int J Methods Psychiatr Res (2009) 1.37
Epidemiology of anxiety disorders. Curr Top Behav Neurosci (2010) 1.36
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol (2014) 1.36
Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am J Psychiatry (2011) 1.33
Maternal smoking and smoking in adolescents: a prospective community study of adolescents and their mothers. Eur Addict Res (2003) 1.32
Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophr Bull (2009) 1.32
Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res (2014) 1.32
Specific phobia: a review of DSM-IV specific phobia and preliminary recommendations for DSM-V. Depress Anxiety (2010) 1.31
Size and burden of social phobia in Europe. Eur Neuropsychopharmacol (2005) 1.31
Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol Med (2007) 1.31
Physical activity and prevalence and incidence of mental disorders in adolescents and young adults. Psychol Med (2007) 1.30
Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom (2007) 1.29
Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey. Int J Methods Psychiatr Res (2002) 1.26
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol (2010) 1.24
A common neural basis for receptive and expressive communication of pleasant facial affect. Neuroimage (2005) 1.24
Panic disorder: a review of DSM-IV panic disorder and proposals for DSM-V. Depress Anxiety (2010) 1.23
Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol (2007) 1.22
[Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care]. Med Klin (Munich) (2006) 1.22
Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord (2007) 1.22
Posttraumatic stress disorder and obesity: evidence for a risk association. Am J Prev Med (2008) 1.21